FDA panel to discuss Avastin for glioblastoma

FDA's Oncologic Drugs Advisory Committee will meet on March 31 to discuss an sBLA from Genentech (NYSE:DNA) for Avastin bevacizumab to treat glioblastoma multiforme. Genentech already markets the mAb ...